Michael Stapleton has resigned as COO of Accelrys, the software division of Pharmacopeia. He will stay with the company until December 31, 2002. Until a replacement is hired, Joseph Mollica, CEO of Pharmacopeia, will serve as acting COO of Accelrys. The company did not provide further details on Stapleton’s departure.
Hanne Dannulat has joined San Diego-based Structural Bioinformatics as European managing director. Dannulat most recently held positions in the areas of sales, sales management, marketing, new product launches, and strategic planning with Glaxo Wellcome and GlaxoSmith-Kline. She will be responsible for planning and management of SBI’s European commercial operation and will report directly to David Muth, president and COO.